| Typicality: | 0.243 |
| Saliency: | 0.340 |
| in patients with ad | 6 | other |
| as of december | 4 | temporal |
| early phase | 2 | temporal |
| trial → show → promising results | 14 |
| trial → shown → promising results | 7 |
| trial → produced → promising results | 4 |
| negative | neutral | positive |
| 0.026 | 0.124 | 0.850 |
| Raw frequency | 25 |
| Normalized frequency | 0.340 |
| Modifier score | 0.300 |
| Perplexity | 72.931 |